136 related articles for article (PubMed ID: 1719651)
21. Interstitial high dose rate brachytherapy in locally progressive or recurrent head and neck cancer.
Krüll A; Friedrich RE; Schwarz R; Thurmann H; Schmelzle R; Alberti W
Anticancer Res; 1999; 19(4A):2695-7. PubMed ID: 10470222
[TBL] [Abstract][Full Text] [Related]
22. Combination of surgical resection and HDR-brachytherapy in patients with recurrent or advanced head and neck carcinomas.
Schiefke F; Hildebrandt G; Pohlmann S; Heinicke F; Hemprich A; Frerich B
J Craniomaxillofac Surg; 2008 Jul; 36(5):285-92. PubMed ID: 18353667
[TBL] [Abstract][Full Text] [Related]
23. The role of pulsed-dose-rate brachytherapy in previously irradiated head-and-neck cancer.
Strnad V; Geiger M; Lotter M; Sauer R
Brachytherapy; 2003; 2(3):158-63. PubMed ID: 15062138
[TBL] [Abstract][Full Text] [Related]
24. [The results of simultaneous radio-chemotherapy in advanced head and neck tumors].
Wendt TG; Wustrow TP; Schalhorn A
Strahlenther Onkol; 1990 Sep; 166(9):569-79. PubMed ID: 2218860
[TBL] [Abstract][Full Text] [Related]
25. High-dose-rate brachytherapy in the treatment of recurrent and residual head and neck cancer.
Glatzel M; Büntzel J; Schröder D; Küttner K; Fröhlich D
Laryngoscope; 2002 Aug; 112(8 Pt 1):1366-71. PubMed ID: 12172246
[TBL] [Abstract][Full Text] [Related]
26. Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Protocol 9911.
Langer CJ; Harris J; Horwitz EM; Nicolaou N; Kies M; Curran W; Wong S; Ang K
J Clin Oncol; 2007 Oct; 25(30):4800-5. PubMed ID: 17947728
[TBL] [Abstract][Full Text] [Related]
27. [Results of temporary interstitial iridium 192 implantation in head and neck tumors].
Thiel HJ; Fietkau R; Sauer R; Rüppel W; Müller RG; Herbst M; Weidenbecher M; Spitzer W
Strahlenther Onkol; 1989 Nov; 165(11):791-6. PubMed ID: 2480652
[TBL] [Abstract][Full Text] [Related]
28. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
29. [Simultaneous radiochemotherapy in locoregional recurrent breast carcinoma after mastectomy. Results in patients with macroscopic residual tumor R2].
Renner H; van Kampen M
Strahlenther Onkol; 1994 Aug; 170(8):441-52. PubMed ID: 8085210
[TBL] [Abstract][Full Text] [Related]
30. [Principles of the simultaneous radiation and polychemotherapy in advanced head and neck carcinoma].
Wustrow TP; Wendt TG; Hartenstein RC
Laryngol Rhinol Otol (Stuttg); 1987 Jul; 66(7):366-72. PubMed ID: 3498864
[TBL] [Abstract][Full Text] [Related]
31. [Radiotherapy with fast neutrons as palliative treatment of advanced recurrences of previously irradiated head and neck tumors].
Micke O; Prott FJ; Schäfer U; Willich N
Rontgenpraxis; 2000; 52(9):287-94. PubMed ID: 10936958
[No Abstract] [Full Text] [Related]
32. Concomitant cisplatin significantly improves locoregional control in advanced head and neck cancers treated with hyperfractionated radiotherapy.
Huguenin P; Beer KT; Allal A; Rufibach K; Friedli C; Davis JB; Pestalozzi B; Schmid S; Thöni A; Ozsahin M; Bernier J; Töpfer M; Kann R; Meier UR; Thum P; Bieri S; Notter M; Lombriser N; Glanzmann C
J Clin Oncol; 2004 Dec; 22(23):4665-73. PubMed ID: 15534360
[TBL] [Abstract][Full Text] [Related]
33. Phase I trial of radiochemotherapy with bendamustine in patients with recurrent squamous cell carcinoma of the head and neck.
Bottke D; Bathe K; Wiegel T; Hinkelbein W
Strahlenther Onkol; 2007 Mar; 183(3):128-32. PubMed ID: 17340070
[TBL] [Abstract][Full Text] [Related]
34. [Radiation sensitivity studies of inoperable and recurrent rectal carcinomas].
Rhomberg W; Eiter H
Strahlenther Onkol; 1989 Jan; 165(1):28-33. PubMed ID: 2464856
[TBL] [Abstract][Full Text] [Related]
35. [Synchronization therapy as a palliative measure in incurable head and neck tumors].
Ganzer U
Laryngol Rhinol Otol (Stuttg); 1985 Jan; 64(1):21-4. PubMed ID: 2578596
[TBL] [Abstract][Full Text] [Related]
36. [Results of the treatment of inoperable recurrences of larynx carcinoma after total laryngectomy].
Sas-Korczyńska B; Korzeniowski S; Skołyszewski J
Otolaryngol Pol; 1993; 47(5):420-6. PubMed ID: 7505055
[TBL] [Abstract][Full Text] [Related]
37. Toxicities Following Stereotactic Ablative Radiotherapy Treatment of Locally-Recurrent and Previously Irradiated Head and Neck Squamous Cell Carcinoma.
Quan K; Xu KM; Zhang Y; Clump DA; Flickinger JC; Lalonde R; Burton SA; Heron DE
Semin Radiat Oncol; 2016 Apr; 26(2):112-9. PubMed ID: 27000507
[TBL] [Abstract][Full Text] [Related]
38. Phase II study of high-dose mitoxantrone in the treatment of recurrent squamous cell carcinoma of the head and neck.
Stewart DJ; Cripps C; Maroun JA
Am J Clin Oncol; 1987 Aug; 10(4):307-9. PubMed ID: 3618542
[TBL] [Abstract][Full Text] [Related]
39. [Palliative radiochemotherapy with Bendamustin for advanced recurrent head and neck tumors].
Rahn AN; Schilcher RB; Adamietz IA; Mose S; Bormeth SB; Böttcher HD
Strahlenther Onkol; 2001 Apr; 177(4):189-94. PubMed ID: 11370553
[TBL] [Abstract][Full Text] [Related]
40. Combined bleomycin and irradiation.
Rygård J; Hansen HS
Can J Otolaryngol; 1975; 4(2):209-12. PubMed ID: 49219
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
